Seroprevalence of hepatitis C virus and associated risk behaviours: A population-based study in San Juan, Puerto Rico

International Journal of Epidemiology

Volumn 34, Issue 3, 2005, Pages 593-599

  Pérez, Cynthia M ^a   Suárez, Erick ^a   Torres, Esther A ^b   Román, Karisse ^a   Colón, Vivian ^a  

^a UNIVERSITY OF PUERTO RICO   (Puerto Rico)

^b UNIVERSITY OF PUERTO RICO SCHOOL OF MEDICINE   (Puerto Rico)

Author keywords

Epidemiology; Hepatitis C; Hispanics; Prevalence; Puerto Rico; Risk behaviours

Indexed keywords

COCAINE; DIAMORPHINE; HEPATITIS ANTIBODY;

DISEASE PREVALENCE; EPIDEMIOLOGY; HEALTH RISK; HEPATITIS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BLOOD TRANSFUSION; CLUSTER ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DEMOGRAPHY; DRUG DEPENDENCE; EDUCATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HISTORY; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INFECTION RISK; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION RESEARCH; PRIORITY JOURNAL; PRISONER; PROBABILITY; PUERTO RICO; RISK ASSESSMENT; SELF REPORT; SEROPREVALENCE; SEX RATIO; STATISTICAL SIGNIFICANCE; TATTOOING; VEIN PUNCTURE;

ADULT; AGE DISTRIBUTION; BLOOD TRANSFUSION; BODY PIERCING; COCAINE-RELATED DISORDERS; FEMALE; HEALTH OCCUPATIONS; HEPATITIS C; HEROIN DEPENDENCE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PUERTO RICO; RISK-TAKING; SEROEPIDEMIOLOGIC STUDIES; SEX DISTRIBUTION; SEXUAL BEHAVIOR; TATTOOING;

ATLANTIC ISLANDS; ATLANTIC OCEAN; CARIBBEAN ISLANDS; GREATER ANTILLES; OCEANIC REGIONS; PUERTO RICO; SAN JUAN [PUERTO RICO]; WORLD;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS;

EID: 20744451112     PISSN: 03005771     EISSN: None     Source Type: Journal    
DOI: 10.1093/ije/dyi059     Document Type: Article

References (39)

1. World Health Organization. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat 1999;6:35-47.
2. Wasley A, Alter MJ. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 2000; 20:1-16.
3. Alter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-62.
4. Martínez J, Rubio CE, Oharriz JJ et al. Hepatitis C antibody in healthy Puerto Rican blood donors: prevalence, hepatic functional and histological abnormalities. Bol Asoc Med P R 1992; 84:94-96.
5. López-Navedo PJ, Lebrón-Rivera R, González-Trapaga J et al. Prevalence of hepatitis C virus infection at three hemodialysis units in the western region of Puerto Rico. Bol Asoc Med P R 1999; 91:100-02.
6. Deseda CC, Sweeney PA, Woodruff BA et al. Prevalence of hepatitis B, hepatitis C and human immunodeficiency virus infection among women attending prenatal clinics in San Juan, Puerto Rico, from 1989-1990. Obstet Gynecol 1995;85:75-78.
7. Colón-Renta M. Perfil histórico del tratamiento del VHC en el Programa de Servicios de Salud Correccional. El Nuevo Dia 2003;May 16(Suplementos): p. 7.
8. Centers for Disease Control and Prevention. Prevention and control of infections with hepatitis viruses in correctional settings. MMWR 2003;52:1-33.
9. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health 2002;92:1789-94.
10. Vlahov D, Nelson KE, Quinn TC, Kendig N. Prevalence and incidence of hepatitis C virus infection among male prison inmates in Maryland. Eur J Epidemiol 1993;9:566-69.
11. Allwright S, Bradley F, Long J, Barry J, Thornton L, Parry JV. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisoners: results of a national cross sectional survey. BMJ 2000;321:78-82.
12. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2001, Vol. 13, pp. 8-12.
13. Puerto Rico Department of Health. Division of Epidemiology, AIDS Surveillance System, 2004.
14. Deren S, Kang SY, Colón HM, Andia JF, Robles RR. HIV incidence among high-risk Puerto Rican drug users: a comparison of East Harlem, New York, and Bayamón, Puerto Rico. J Acquir Immune Defic Syndr 2004;36:1067-74.
15. Hardin JW, Hilbe JM. Generalized Estimating Equations. Boca Raton, FL: Chapman & Hall/CRC, 2003, pp. 59-66, 167-169.
16. Domínguez A, Bruguera M, Vidal J, Plans P, Salleras L. Community-based seroepidemiological survey of HCV infection in Catalonia, Spain. J Med Virol 2001;65:688-93.
17. Dubois F, Desenclos JC, Mariotte N, Goudeau A, and the Collaborative Study Group. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution and risk factors. Hepatology 1997;25:1490-96.
18. Campello C, Poli A, Dal MG, Besozzi-Valentini F. Seroprevalence, viremia, and genotype distribution of hepatitis C virus: a community-based population study in northern Italy. Infection 2002;30:7-12.
19. Colón HM, Robles RR, Deren S et al. Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York, and Bayamón, Puerto Rico. J Acquir Immune Defic Syndr 2001;27:405-13.
20. Deren S, Oliver-Vélez D, Finlinson A et al. Integrating qualitative and quantitative methods: comparing HIV-related risk behaviors among Puerto Rican drug users in Puerto Rico and New York. Subst Use Misuse 2003;38:1-24.
21. Deren S, Robles R, Andia J, Colón HM, Kang SY, Perlis T. Trends in HIV seroprevalence and needle sharing among Puerto Rican drug injectors in Puerto Rico and New York: 1992-1999. J Acquir Immune Defic Syndr 2001;26:164-69.
22. Finlinson HA, Oliver-Vélez D, Colón HM et al. Syringe acquisition and use of syringe exchange programs by Puerto Rican drug injectors in New York and Puerto Rico: comparisons based on quantitative and qualitative methods. AIDS Behav 2000; 4:341-51.
23. Robles RR, Matos TD, Colón HM et al. Determinants of health care use among Puerto Rican drug users in Puerto Rico and New York City. Clin Infect Dis 2003;37:S392-403.
24. National Institutes of Health Consensus Development Conference. Management of hepatitis C. Hepatology 2002; 36:S3-20.
25. Colón H, Rivera M, Marrero CA, Robles R, López CM. Puerto Rico Substance Abuse Needs Assessment Program: 2002 Provider Survey Final Results. Mental Health and Anti-Addiction Services Administration. San Juan, Puerto Rico, September 2002.
26. Estrada AL. Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users. Public Health Rep 2002;117:S126-34.
27. Haley RW, Fischer RP. The tattooing paradox: are studies of acute hepatitis adequate to identify routes of transmission of subclinical hepatitis C infection? Arch Intern Med 2003; 163:1095-98.
28. Nishioka SA, Gyorkos TW, Joseph L, Collet JP, Maclean JD. Tattooing and risk for transfusion-transmitted diseases: the role of the type, number and design of the tattoos and the condition in which they were performed. Epidemiol Infect 2002;128:63-71.
29. Hellard ME, Hocking JS, Crofts N. The prevalence and the risk behaviours associated with the transmission of hepatitis C virus in Australian correctional facilities. Epidemiol Infect 2004; 132:409-15.
30. Reyes JC, Robles RR, Colón HM et al. Hepatitis C virus infection among street-recruited, injection drug users in San Juan, Puerto Rico. 132nd Annual Meeting of the American Public Health Association, November 6-10, 2004, Washington, DC, Abstract 84340.
31. Aach RD, Stevens CE, Hollinger FB et al. Hepatitis C virus infection in post-transfusion hepatitis: an analysis with first- and second-generation assays. N Engl J Med 1991; 325:1325-29.
32. Esteban JI, González A, Hernández JM et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990; 323:1107-12.
33. Terrault NA. Sexual activity as a risk factor for hepatitis C. Hepatology 2002;36:S99-105.
34. Vandelli C, Renzo F, Romano L et al. Lack of evidence of sexual transmission of hepatitis C among monogamous couples: results of a 10-year prospective follow-up study. Am J Gastroenterol 2004;99:855-59.
35. Zylberberg H, Thiers V, Lagorce D et al. Epidemiological and virological analysis of couples infected with hepatitis C virus. Gut 1999;45:112-16.
36. Thomas DL. Hepatitis C and human immunodeficiency virus infection. Hepatology 2002;36:S201-09.
37. Desai RA, Rosenheck RA, Agnello V. Prevalence of hepatitis C virus infection in a sample of homeless veterans. Soc Psychiatry Psychiatr Epidemiol 2003;38:396-401.
38. Rosenblum A, Nuttbrock L, McQuistion HL, Magura S, Joseph H. Hepatitis C and substance use in a sample of homeless people in New York City. J Addict Dis 2001;20:15-25.
39. Colón HM, Robles RR, Sahai H. The validity of drug use self-reports among hard core drug users in a household survey in Puerto Rico: comparison of survey responses of cocaine and heroin use with hair tests. Drug Alcohol Depend 2002;67:269-79.